These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 26103989)
21. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226 [TBL] [Abstract][Full Text] [Related]
22. Convection-enhanced drug delivery: prospects for glioblastoma treatment. Barua NU; Gill SS CNS Oncol; 2014; 3(5):313-6. PubMed ID: 25363001 [No Abstract] [Full Text] [Related]
23. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. Grahn AY; Bankiewicz KS; Dugich-Djordjevic M; Bringas JR; Hadaczek P; Johnson GA; Eastman S; Luz M J Neurooncol; 2009 Nov; 95(2):185-197. PubMed ID: 19466380 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant convection-enhanced delivery for the treatment of brain tumors. Kreatsoulas D; Damante M; Cua S; Lonser RR J Neurooncol; 2024 Jan; 166(2):243-255. PubMed ID: 38261143 [TBL] [Abstract][Full Text] [Related]
25. Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model. Haryu S; Saito R; Jia W; Shoji T; Mano Y; Sato A; Kanamori M; Sonoda Y; Sampetrean O; Saya H; Tominaga T J Neurooncol; 2018 Jan; 136(1):23-31. PubMed ID: 28929335 [TBL] [Abstract][Full Text] [Related]
26. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Chen PY; Ozawa T; Drummond DC; Kalra A; Fitzgerald JB; Kirpotin DB; Wei KC; Butowski N; Prados MD; Berger MS; Forsayeth JR; Bankiewicz K; James CD Neuro Oncol; 2013 Feb; 15(2):189-97. PubMed ID: 23262509 [TBL] [Abstract][Full Text] [Related]
27. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
28. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Juratli TA; Schackert G; Krex D Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764 [TBL] [Abstract][Full Text] [Related]
29. Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride. Saito R; Sonoda Y; Kumabe T; Nagamatsu K; Watanabe M; Tominaga T J Neurosurg Pediatr; 2011 May; 7(5):522-6. PubMed ID: 21529193 [TBL] [Abstract][Full Text] [Related]
30. Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints. Mathew EN; Berry BC; Yang HW; Carroll RS; Johnson MD Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163633 [TBL] [Abstract][Full Text] [Related]
31. Convection-enhanced delivery in clinical trials. Hall WA; Rustamzadeh E; Asher AL Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423 [TBL] [Abstract][Full Text] [Related]
32. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230 [TBL] [Abstract][Full Text] [Related]
33. Convection-Enhanced Delivery for Management of Malignant Gliomas. Prabhu SS Prog Neurol Surg; 2018; 32():152-158. PubMed ID: 29990981 [TBL] [Abstract][Full Text] [Related]
34. Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma. Sonabend AM; Carminucci AS; Amendolara B; Bansal M; Leung R; Lei L; Realubit R; Li H; Karan C; Yun J; Showers C; Rothcock R; O J; Califano A; Canoll P; Bruce JN Neuro Oncol; 2014 Sep; 16(9):1210-9. PubMed ID: 24637229 [TBL] [Abstract][Full Text] [Related]
35. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme. White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221 [TBL] [Abstract][Full Text] [Related]
37. Convection enhanced delivery for the treatment of malignant gliomas: symposium review. Vogelbaum MA J Neurooncol; 2005 May; 73(1):57-69. PubMed ID: 15933820 [TBL] [Abstract][Full Text] [Related]
38. Convection-enhanced delivery: from mechanisms to clinical drug delivery for diseases of the central nervous system. Saito R; Tominaga T Neurol Med Chir (Tokyo); 2012; 52(8):531-8. PubMed ID: 22976134 [TBL] [Abstract][Full Text] [Related]